| Health / Medical Topics |
SU6668
A substance being studied in the treatment of cancer. SU6668 blocks proteins involved in the growth and spread of cancer cells. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of tyrosine kinase inhibitor and a type of antiangiogenesis agent. Also called orantinib and SU006668. (NCI Dictionary)
YOU MAY ALSO LIKE
A substance that has been studied in the treatment of cancer. It belongs to the families of drugs called angiogenesis inhibitors and…
A substance that inhibits the tyrosine kinase activity of fibroblast growth factor receptor 1, tyrosine phosphorylation of the PDGF receptor and the…
A drug used to treat certain types of pancreatic cancer. It is also used to treat gastrointestinal stromal tumors (GIST) in some…
An anticancer drug that works by inhibiting a cancer cell growth factor. Also called leflunomide.
An orally-active, tyrosine kinase receptor inhibitor with potential antitumor activity. SU014813 binds to and inhibits the phosphorylation of vascular endothelial growth factor…
A drug used to treat certain types of pancreatic cancer. It is also used to treat gastrointestinal stromal tumors (GIST) in some…
